Anbio Biotechnology Pursues U.S. IPO For Its IVD Products Launch
Anbio Biotechnology seeks IPO funding to expand in the IVD market. Discover why NNNN stock’s potential is tempered by ...
Anbio Biotechnology Files for 1.6 Million-Share IPO
Anbio Biotechnology filed for a 1.6 million-share initial public offering with the Securities and Exchange Commission. The company said Tuesday it expects the IPO to price between $5 and $6 per share, ...
360dx5d
German IVD Firm Anbio Biotechnology Files for IPO
NEW YORK – Anbio Biotechnology filed this week a preliminary prospectus for an initial public offering on the Nasdaq exchange of 1.6 million shares at an anticipated offering price in the range of $5 ...
The Tribune12d
Explore the Boundless Potential of Biotechnology with MSc Biotechnology at JAIN (Deemed-to-be University)
Bangalore (Karnataka) [India], December 27: Biotechnology, a transformative field at the crossroads of science and technology, continues to revolutionize industries globally. From healthcare to ...
Yahoo Finance2d
MAIA Biotechnology, Inc. (MAIA)
CHICAGO, December 16, 2024--MAIA Biotechnology Granted FDA Rare Pediatric Disease Designation for THIO as a Treatment for Pediatric High-Grade Gliomas CHICAGO, December 03, 2024--MAIA ...